Newsletter Subject

Daily Headlines: Off-Label; Angina and Tennis; To Bypass or Not to Bypass

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Mar 12, 2016 12:01 PM

Email Preheader Text

Add us to your address book or trusted sender list to help ensure delivery. To view in your browser,

Add us to your address book or trusted sender list to help ensure delivery. To view in your browser, [click here]. Daily Headlines Saturday, March 12, 2016 [Off-Label; Angina and Tennis; To Bypass or Not to Bypass] [Cardiovascular Daily presents a review of the cardiovascular news from the week of March 7, 2016] [Read more] [Social Media Complicate Ob/Gyn Care] [Video] [Scare stories on mesh implants, Essure creates challenges for clinicians] [Read more] [Patient-Reported Outcomes Improve With Current RA Tx] [CME] [Xeljanz, Humira cut disease burden and improved quality of life] [Read more] ADVERTISEMENT [This Week's Survey: Should FDA Have Yielded on Off-Label Marketing?] The [FDA won't appeal a court ruling] permitting Amarin to make truthful and non-misleading statements about off-label uses of its triglyceride-lowering fish oil product Vascepa Did the agency make the right call? [Vote] [EBCC: Partial-Breast RT, Dose-Dense Chemo Win Out] [CME] [Alternative strategies improve survival in early breast cancer] [Read more] [Insurers, Academics Protest High-Cost Drugs, Propose Solutions] [Allowing Medicare to negotiate drug prices seen as useful step] [Read more] [Didn't Take That IVC Filter Out? Consider IVC Thrombosis] [Another reason to 'pull it out as soon as is safe and reasonable'] [Read more] [Friday Feedback: Is There a Future for Uterus Transplant?] [Many risks with a procedure that saves no lives] [Read more] [5 Memorable Questions to End a Job Interview] [Must reads about the latest news and trends in healthcare careers] [Read more] [EndoBreak: Mismatched Kidney Transplants; Drinking Man's Diet] [News and highlights from around the endocrinology world] [Read more] [Should FDA Overlook Evidence Gaps for Life-Saving Devices?] [Clinicians argue the balance between patient needs and evidence base] [Read more] [House Panel Presses Valeant to Release Documents on Drug Pricing] [Company refusing to provide internal communications] [Read more] [Tweet of the Week: The Donald J. Trump Resuscitation Room] [Making critical care great again] [Read more] [Actemra Found Steroid-Sparing in Vasculitis] [CME] [Tocilizumab induced remission, prevented relapse in giant cell arteritis] [Read more] [Do You Prescribe Opioids for Chronic Pain?] [Is chronic pain a safe indication for an opioid rx?] [Read more] Meeting Coverage - [SGO]: Coverage of the Society of Gynecologic Oncology meeting begins March 20. [See all stories.] - : Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [See all stories.] ADVERTISEMENT CME SPOTLIGHTS [Get CLL @Point of Care, clinical decision support platform for CLL diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Asthma @Point of Care, Clinical Decision Support Platform for Asthma Diagnosis, Treatment & Management] [Source: @Point of Care] [[more]] [Seeing Into the Future: Systemic Control of Diabetes to Help Prevent Diabetic Eye Disease] [Source: Global Education Group and FocusCME] [[more]] [Update in Basal Insulins: Your Questions Answered] [Source: Endocrine Society] [[more]] [Improving Women's Health Outcomes in MS: A Multidisciplinary Approach] [Source: Penn State Hershey College of Medicine] [[more]] [Get Stroke Prevention in Afib/VTE @Point of Care, support platform for diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Rheumatoid Arthritis @Point of Care, decision support platform for RA diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Prostate Cancer @Point of Care, clinical decision support platform for diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get PD @Point of Care, clinical decision support platform for parkinson's diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get NSCLC @Point of Care, clinical decision support platform for lung cancer diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get MDS/AML @Point of Care, support platform for MDS and AML diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Multiple Sclerosis @Point of Care, decision support platform for MS diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Multiple Myeloma @Point of Care, support platform for multiple myeloma diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Immuno Oncology @Point of Care, support platform for cancer diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get IPF @Point of Care, clinical decision support platform for IPF diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Hypoparathyroidism @Point of Care, support platform for hypoparathyroidism diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get HepC @Point of Care, clinical decision support platform for Hepatitis C diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Gynecologic Cancers @Point of Care, support platform for cancer diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get Cystic Fibrosis @Point of Care, clinical decision support platform for CF diagnosis, treatment & management] [Source: @Point of Care] [[more]] [Get COPD @Point of Care, clinical decision support platform for COPD diagnosis, treatment & management] [Source: @Point of Care] [[more]] [A property of Everday Health] © 2016 MedPage Today, LLC. All rights reserved. Use of this site constitutes acceptance of the MedPageToday.com [terms of use] and [privacy policy]. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. --------------------------------------------------------------- [REMOVE me from this list] | [Manage my e-mail settings]

Marketing emails from medpagetoday.com

View More
Sent On

08/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

06/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.